Inositol 1,4,5-trisphosphate receptors (IP 3 R) are intracellular Ca 2+ channels. Most animal cells express mixtures of the three IP 3 R subtypes encoded by vertebrate genomes. Adenophostin A (AdA) is the most potent naturally occurring agonist of IP 3 R and it shares with IP 3 the essential features of all IP 3 R agonists, namely structures equivalent to the 4,5-bisphosphate and 6-hydroxyl of IP 3 . The two essential phosphate groups contribute to closure of the clam-like IP 3 -binding core (IBC), and thereby IP 3 R activation, by binding to each of its sides (the a-and b-domains). Regulation of the three subtypes of IP 3 R by AdA and its analogues has not been examined in cells expressing defined homogenous populations of IP 3 R. We measured Ca 2+ release evoked by synthetic adenophostin A (AdA) and its analogues in permeabilized DT40 cells devoid of native IP 3 R and stably expressing single subtypes of mammalian IP 3 R. The determinants of high-affinity binding of AdA and its analogues were indistinguishable for each IP 3 R subtype. The results are consistent with a cation-p interaction between the adenine of AdA and a conserved arginine within the IBC a-domain contributing to closure of the IBC. The two complementary contacts between AdA and the a-domain (cation-p interaction and 30-phosphate) allow activation of IP 3 R by an analogue of AdA (30-dephospho-AdA) that lacks a phosphate group equivalent to the essential 5-phosphate of IP 3 . These data provide the first structure-activity analyses of key AdA analogues using homogenous populations of all mammalian IP 3 R subtypes. They demonstrate that differences in the Ca 2+ signals evoked by AdA analogues are unlikely to be due to selective regulation of IP 3 R subtypes.
Introduction
Inositol 1,4,5-trisphosphate receptors (IP 3 R) are intracellular Ca 2+ channels that are expressed in almost all animal cells. They allow release of Ca 2+ from intracellular stores in response to the many stimuli that activate phospholipase C [1, 2] . The genomes of vertebrates encode three closely related IP 3 R subtypes (IP 3 R1-3), and most cells from vertebrates express functional IP 3 R that are homo-or hetero-tetrameric assemblies of these IP 3 R subtypes and their splice variants [3] . The physiological significance of this IP 3 R diversity is poorly understood, and nor are there ligands that usefully discriminate between IP 3 R subtypes. It is, however, clear that activation of IP 3 R is initiated by binding of IP 3 to the conserved IP 3 -binding core (IBC, residues 224-604 of IP 3 R1) of each IP 3 R subunit [4] . Mixed populations of IP 3 R in native cells make it difficult to define unambiguously the functional properties of each IP 3 R subtype. Stable heterologous expression of mammalian IP 3 R in the only vertebrate cell line engineered to lack all endogenous IP 3 R (DT40 KO cells) [5] provides an effective means of addressing this difficulty [6] . We previously used DT40 cells expressing homogeneous populations of each mammalian IP 3 R subtype to define structure-activity relationships for key endogenous and synthetic inositol phosphates [7] . Here, we extend the approach to examine the interactions of each IP 3 R subtype with adenophostin A (1, AdA) and its most important analogues [8] ( Figure 1A) .
AdA, originally isolated from Penicillium brevicompactum [9, 10] and later synthesized [11] , is a potent agonist of IP 3 R. It is also resistant to degradation by the enzymes that degrade IP 3 via phosphorylation or dephosphorylation [10] . Although AdA is based on a glucose ring, rather than the inositol ring of IP 3 , its structure retains the key functional groups of IP 3 that are known to be essential for IP 3 activity at IP 3 R [12] ( Figure 1A ). Considerable evidence supports the original suggestion [10] that the essential 4,5-bisphosphate and 6-hydroxyl of IP 3 are effectively mimicked by the 40,30-bisphosphate and 20-hydroxyl of AdA (red highlights in Figure 1A ). The interactions that allow AdA to bind to IP 3 R with about 10-fold greater affinity than IP 3 have been more difficult to resolve. One view was that the 29-phosphate of AdA is equivalent to the 1-phosphate of IP 3 and, like the latter [13] (blue in Figure 1A ), contributes to high-affinity binding to the IBC. The suggestion was that the 29-phosphate of AdA forms a stronger interaction with the IBC than does the 1-phosphate of IP 3 . Our recent analyses have challenged this idea and instead suggest that a cation-p interaction between the adenine ring of AdA and a guanidinium side chain of an arginine residue within the a-domain of the IBC (R504 in IP 3 R1) may be a more important determinant of the increased affinity of AdA for IP 3 R [12] .
The high-affinity and metabolic stability of AdA have generated considerable interest in both the synthesis of AdA analogues and their application to analyses of IP 3 R activation and associated changes in cytosolic Ca 2+ signalling [12] . There has, however, been no systematic analysis of the activities of AdA or its analogues with defined populations of homogenous IP 3 R subtypes. The need for such analyses is particularly important in attempting to explain results in which Ca 2+ signals evoked by IP 3 differ from those evoked by AdA [14, 15, 16, 17, 18, 19, 20, 21] , or where different analogues of AdA evoke different cellular responses [reviewed in 12, 22] . Here we use DT40 cells in which all endogenous IP 3 R have been genetically inactivated [5] to stably express homogenous populations of mammalian IP 3 R subtypes and thereby define structure-activity relationships for AdA and its key analogues for each IP 3 R subtype.
Materials and Methods

Materials
Sources of most reagents were provided in a previous publication [7] . The structures of the ligands used and their abbreviations are shown in Figure 1A . IP 3 was from Alexis Biochemicals (Nottingham, UK). AdA [23] , imidophostin [24] , ribophostin [25] , furanophostin [26] , manno-AdA and xylo-AdA [27] , 30-dephospho AdA and 40-dephospho AdA [28] , and 29-dephospho AdA were synthesized, purified and characterized as previously described.
Measurement Ca 2+ Release by IP 3 Receptors
From quantitative analyses of western blots using antisera that selectively recognise each IP 3 R subtype or react equally with all three subtypes, we established that in the DT40 cells used, levels of IP 3 R expression (relative to IP 3 R3) were IP 3 R1 (7168%, n = 3), IP 3 R2 (4865%) and IP 3 R3 (100%) [7] . It is impracticable to achieve identical levels of IP 3 R expression for each cell line, and differences (albeit modest in our cell lines) may affect both the size of the IP 3 -sensitive Ca 2+ pool and its sensitivity to IP 3 [29] . The different levels of IP 3 R expression do not compromise the analyses reported here, which are entirely concerned with relative potencies of AdA analogues for each IP 3 R subtype (see below).
A comprehensive description of the methods used to measure free [Ca 2+ ] within the endoplasmic reticulum of permeabilized DT40 cells was provided in preceding publications [7, 30] . Briefly, the endoplasmic reticulum of DT40 cells stably expressing each of the three mammalian IP 3 R subtypes was loaded with a low-affinity Ca 2+ indicator (Mag fluo-4) [30] . After permeabilization of the plasma membrane with saponin (10 mg/mL, ,4 min, 37uC), the permeabilized cells in cytosol-like medium (CLM) were distributed into 96-well plates at 20uC. Addition of MgATP (1.5 mM) then allowed active Ca 2+ accumulation, which was monitored at intervals of ,1 s using a FlexStation 3 fluorescence plate-reader (MDS Analytical Devices). CLM had the following composition: 140 mM KCl, 20 mM NaCl, 1 mM EGTA, 20 We note that Table 1 reports pooled results from experiments collected over a considerable period, whereas DpEC 50 values, like those shown in Table 2 , compare only paired values. The latter provide the most robust means of comparing agonist potencies. Results are expressed as means 6 SEM from n independent experiments, with each experiment performed in triplicate.
Statistical comparisons used Student's t-test or ANOVA followed by Bonferroni's post hoc test, as appropriate, with P,0.05 considered significant. Because not all comparisons of the relative potencies of AdA and IP 3 were paired, the SEM of this DpEC 50 value was calculated from:
where, s p is the estimate of the population variance:
where, s 1 and s 2 are the sample standard deviations, and n 1 and n 2 are the sample sizes [31] .
Results
Quantal Ca 2+ Release Evoked by AdA and IP 3
The kinetics of IP 3 -evoked Ca 2+ release from intracellular stores are unexpectedly complex. It is widely observed that under conditions where Ca 2+ uptake into the endoplasmic reticulum (ER) is inhibited, submaximally effective concentrations of IP 3 rapidly release only a fraction of the IP 3 -sensitive Ca 2+ stores [32] . Thereafter, there is either no, or a massively reduced, effect of IP 3 on the rate of Ca 2+ release. The mechanisms underlying this pattern of response, known as quantal Ca 2+ release [33] , remain AdA is a Potent Agonist of All Three IP 3 
Receptor Subtypes
The results shown in Figure 2 and Tables 1 and 2 demonstrate that AdA is ,10-times more potent than IP 3 at each IP 3 R subtype, and for each subtype, maximally effective concentrations of IP 3 and AdA release the same fraction of the intracellular Ca 2+ stores. This is consistent with many analyses of IP 3 and AdA in a variety of cell types using both functional and binding assays, in which AdA behaves as a full agonist with ,10-fold greater affinity than IP 3 [reviewed in 8]. Our results do, however, provide the first direct demonstration that AdA interacts similarly with all three IP 3 R subtypes. Subsequent experiments examine the interactions between key analogues of IP 3 and AdA with each IP 3 R subtype.
Trimming the Adenosine Moiety of AdA Reduces its Potency at All IP 3 Receptor Subtypes Systematic trimming of the adenosine moiety of AdA successively produces imidophostin (which lacks the pyrimidine ring of AdA), ribophostin (in which a methoxy group replaces the adenine moiety of AdA) and furanophostin (in which only the furanoid ring remains) ( Figure 1A ). Maximally effective concentrations of each of these analogues released the same fraction of the intracellular Ca 2+ stores as AdA in cells expressing each of the three IP 3 R subtypes, and each analogue was ,5-10-fold less potent than AdA (Figure 3, Tables 1 and 2 ). These results are consistent with previous analyses of IP 3 R in hepatocytes, which express predominantly IP 3 R2 [24, 36] , with analyses of binding of ribophostin and furanophostin to an N-terminal fragment of IP 3 R1 [12] , and with evidence from other analogues that trimming the adenosine moiety decreases affinity for cerebellar IP 3 R, which are largely IP 3 R1 [37] .
These results are consistent with our earlier conclusion that the 10-fold greater affinity of AdA relative to IP 3 requires the adenine moiety of AdA positioned to allow it to form a cation-p interaction with Arg-504 in the a-domain of the IBC of IP 3 R1, a residue that is conserved in all IP 3 R subtypes [8, 12] (Figure 3G ). We suggest that this interaction of AdA with IP 3 R is likely to be similar for all IP 3 R subtypes.
Hydroxyl Moieties that are Important for IP 3 Binding are Less Important for Binding of AdA
The 50-CH 2 OH and 20-OH substituents of the glucose ring of AdA are thought to mimic the 3-OH and 6-OH of IP 3 , respectively ( Figure 1A) . A structure equivalent to the 6-OH of IP 3 is an essential feature of all inositol phosphate analogues that bind to IP 3 R [13, 38, 39] and inversion of its orientation from equatorial to axial reduces affinity by more than 100-fold at all IP 3 R subtypes [40] . It is therefore surprising, but consistent with previous analyses of native hepatic IP 3 R [36] , that manno-AdA, which differs from AdA only in the orientation of its 20-OH, should be only 5-to 10-fold less potent than AdA at each IP 3 R subtype ( Figures 4A and B, Tables 1 and 2 ). Why, when the 6-OH of IP 3 and 20-OH of AdA seem to be analogous in the ligand structures, should these moieties make such different contributions to the interactions of IP 3 and AdA with IP 3 R?
The 6-OH of IP 3 interacts, through a water molecule, with a lysine residue (K569) in the IBC [41] and, by interacting with the adjacent 1-phosphate, it has also been proposed to influence the behaviour of the 4,5-bisphosphate moiety of IP 3 [42] . The latter interaction is unlikely to contribute to AdA binding because the structures equivalent to the 6-OH (20-OH of AdA) and the 1-phosphate of IP 3 (29-phosphate of AdA) are in different rings in AdA ( Figure 1A) . We suggest that the lesser importance in AdA of a structure equivalent to the essential 6-OH of IP 3 comes from this hydroxyl mediating a relatively minor interaction with K569 in AdA, whereas for IP 3 it contributes also to appropriately orienting the critical 4,5-bisphosphate moiety.
The 3-OH group, although less important than the 6-OH, is another feature of IP 3 that contributes to high-affinity binding [43] . Our recent analyses of the functional effects of 3-deoxy-IP 3 established that it was ,40-fold less potent than IP 3 at all three IP 3 R subtypes [7] . This is consistent with earlier work showing that 3-deoxy-IP 3 and analogues with other modifications of the 3-position have reduced affinity for the three IP 3 R subtypes [40] . However, the equivalent modification of AdA, removal of its 50-CH 2 OH to give xylo-AdA ( Figure 1A) , had no significant effect on its potency at any IP 3 R subtype ( Figures 4C and D , Tables 1 and  2 ). This is consistent with a previous functional analysis of hepatic IP 3 R, where xylo-AdA was only marginally less potent than AdA (DpEC 50 ,0.28) [36] . Our results suggest that despite the apparent structural similarity between the 3-OH of IP 3 and the 50-CH 2 OH of AdA ( Figure 1A) , the two hydroxyl groups do not contribute similarly to ligand binding. Previous analyses of IP 3 analogues suggested that replacing the 3-OH with the larger CH 2 OH moiety caused the affinity to decrease by no more than 7-fold [40] . A partial explanation for the lack of effect of removing the 50-CH 2 OH of AdA may therefore be that this moiety is less readily accommodated than a hydroxyl group in the IBC. This would suggest that an analogue of AdA in which the 50-CH 2 OH is replaced by 50-OH might bind with increased affinity. We are unaware of such an analogue having been synthesized. The larger substituent at the 50-position of AdA is, however, unlikely to provide the sole explanation for it making no discernible contribution to binding.
The 29-phosphate of AdA is not a Super-optimal Mimic of the 1-phosphate of IP 3 It has been suggested that the 29-phosphate of AdA interacts with the IBC in a manner that allows it to behave as a superoptimal mimic of the 1-phosphate of IP 3 [44, 45] . However, our recent study combining structure-activity analyses with mutagenesis of the binding site suggest that the 1-phosphate of IP 3 is more important for binding than is the 29-phosphate of AdA [12] . Removal of the 1-phosphate from IP 3 (to give (4,5)IP 2 ) caused its potency and affinity for IP 3 R1 to decrease by ,100-fold [12] , whereas removal of the 29-phosphate from AdA (29-dephospho AdA) causes a decrease in potency of ,17-fold in IP 3 R1 ( Figure 5 ) and ,40-fold decreases in potency were obtained with 29-dephospho AdA and IP 3 R2 and IP 3 R3 ( Figure 5 , Table 1 and 2). These results establish that for all three IP 3 R subtypes, the enhanced affinity of AdA is not due to its 29-phosphate interacting more effectively than the 1-phosphate of IP 3 with the IBC.
A Bisphosphate Moiety is not Essential for Activation of IP 3 Receptors by AdA
All known active analogues of IP 3 have structures equivalent to its 4,5-bisphosphate moiety [13] . Structures of the IBC with and without IP 3 bound provide a rationale for this requirement by revealing that these two phosphate groups contact opposite sides (the a-and b-domains) of the clam-like IBC, closure of which initiates IP 3 R activation [4, 41] . Substantial evidence suggests that the 40,30-bisphosphate moiety of AdA mimics the critical 4,5-bisphosphate of IP 3 [8] (Figure 1A) .
40-dephospho-AdA at concentrations up to 300 mM failed to evoke Ca 2+ release via any IP 3 R subtype ( Figure 6A ). This is consistent with previous analyses by both functional and binding assays of IP 3 R1 [28, 46] . 30-dephospho-AdA did, however, cause detectable Ca 2+ release albeit with much reduced potency ( Figure 6B ). The synthetic route used to prepare 30-dephosphoAdA makes it extremely unlikely that the activity could be due to minor contamination with AdA or related structures with a vicinal bisphosphate moiety. Maximal attainable concentrations of 30-dephospho-AdA (300 mM) failed to release the entire IP 3 -sensitive Ca 2+ store, but comparison of the concentrations required to achieve the same submaximal Ca 2+ release suggests that 30-dephospho-AdA is ,10,000-fold less potent than AdA at all three IP 3 R subtypes. With such a massive reduction in potency the lesser sensitivity of DT40-IP 3 R3 cells to AdA means that even the highest practicable concentration of 30-dephospho-AdA (300 mM) is close to the threshold for detecting Ca 2+ release ( Figure 6B ). The inability of high concentrations of 30-dephospho-AdA to release the entire IP 3 -sensitive Ca 2+ store is likely to be due solely to its reduced affinity rather than reduced efficacy. A concentration of 30-dephospho-AdA (30 mM) that caused detectable Ca 2+ release via IP 3 R1 (,2165%) had no effect on the sensitivity of the Ca 2+ release evoked by a subsequent addition of IP 3 . The pEC 50 was 7.0060.02 and 7.0460.06 (n = 3) for (1,4,5)IP 3 alone and in the presence of 30-dephospho-AdA, respectively ( Figure 6C) . A partial agonist would be expected to shift the sensitivity to higher concentrations of IP 3 . These results suggest that 30-dephosphoAdA is a low-affinity full agonist of IP 3 R.
These results extend our previous analyses of IP 3 R1 by demonstrating that for all IP 3 R subtypes, the 40-phosphate group of AdA is essential for activity, whereas the 30-phosphate is important but not essential. 30-dephospho-AdA is the only known agonist of IP 3 R to lack a structure equivalent to the 4,5-bisphosphate moiety of IP 3 .
Discussion
AdA is a high-affinity full agonist of IP 3 R that has been extensively used to explore the behaviour of IP 3 R [reviewed in8]. The activity of AdA has been confirmed in many cell types, but hitherto there has been no assessment of its activity in homogenous populations of IP 3 R subtypes. We have demonstrated that AdA is ,10-fold more potent than IP 3 R at each IP 3 R subtype (Figure 2 , Tables 1 and 2) , and the structural determinants of its high-affinity interaction with IP 3 R are similar for all three IP 3 R subtypes. Contrary to an earlier suggestion that the 29-phosphate of AdA mediates its enhanced affinity by forming a stronger interaction with the IBC than the analogous 1-phosphate of IP 3 , we find that the 1-phosphate makes a greater contribution to IP 3 binding than does the 29-phosphate of AdA ( Figure 5 ) [12] . A more likely explanation for the enhanced affinity of AdA is a cation-p interaction between its adenine moiety and R504 within the asubunit of the IBC ( Figure 3G ) [28] . That explanation is supported by results for each IP 3 R subtype showing that truncation of the adenosine moiety of AdA brings the potency of the resulting analogues (imidophostin, ribophostin and furanophostin) close to that of IP 3 ( Figure 3) .
A key step in the initial activation of IP 3 R by IP 3 appears to be closure of its clam-like IBC as the 4-phosphate of IP 3 contacts one side of the clam (its b-domain) and the 5-phosphate contacts the other side (a-domain) [4] . That mechanism provides a satisfying explanation for the long-standing observation that all inositol phosphates that activate IP 3 R share this essential 4,5-bisphosphate moiety. AdA is different in that its 40-phosphate (analogous to the 4-phosphate of IP 3 , Figure 1A ) is essential, but 30-dephospho-AdA retains activity at all three IP 3 R subtypes, albeit with very low affinity ( Figure 6 ). We suggest that for AdA, the need for the bisphosphate moiety to cause closure of the IBC can be partially replaced for all IP 3 R subtypes by having an interaction between the adenine of AdA and the a-domain substitute for the interaction between the 30-phosphate (analogous to the 5-phosphate of IP 3 ) and the a-domain [28] . Finally, whereas the 6-OH and, to a lesser extent, the 3-OH of IP 3 are important for IP 3 binding, the equivalent structures within AdA play lesser roles. Both store-operated Ca 2+ entry, which is triggered by depletion of IP 3 -sensitive Ca 2+ stores [47] , and the spatial organization of subcellular Ca 2+ signals have been reported to be differentially affected by IP 3 , AdA or its analogues [14, 16, 17, 19, 21, 22] . Our present results, which demonstrate that AdA structure-activity relationships are similar for all IP 3 R subtypes, suggest that different physiological effects of IP 3 , AdA or its analogues are more likely to result from differences in their affinities, kinetics or rates of degradation than from selective interactions with different IP 3 R subtypes.
Author Contributions Figure 6 . Structures equivalent to the 4,5-bisphosphate of IP 3 are not essential for AdA activity. (A, B) 
